APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Obsessive-Compulsive Disorder Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Obsessive-Compulsive Disorder Drugs Market Analysis and Forecast 2026-2032

Report ID 174018370222 December 2025193 pages

Choose your research edition.

Industry ResearchObsessive-Compulsive Disorder Drugs Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Obsessive-Compulsive Disorder Drugs Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Obsessive-Compulsive Disorder Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Obsessive-Compulsive Disorder Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Obsessive-Compulsive Disorder Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Obsessive-Compulsive Disorder Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Obsessive-Compulsive Disorder Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Obsessive-Compulsive Disorder Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Obsessive-Compulsive Disorder Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Obsessive-Compulsive Disorder Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Obsessive-Compulsive Disorder Drugs include H. Lundbeck AS, GlaxoSmithKline Plc, Pfizer Inc., Eli Lilly and Co. and Novartis AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Obsessive-Compulsive Disorder Drugs, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Obsessive-Compulsive Disorder Drugs, also provides the revenue of main regions and countries. Of the upcoming market potential for Obsessive-Compulsive Disorder Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Obsessive-Compulsive Disorder Drugs revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Obsessive-Compulsive Disorder Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Obsessive-Compulsive Disorder Drugs revenue, projected growth trends, production technology, application and end-user industry.

Obsessive-Compulsive Disorder Drugs Segment by Company

H. Lundbeck AS

GlaxoSmithKline Plc

Pfizer Inc.

Eli Lilly and Co.

Novartis AG

Obsessive-Compulsive Disorder Drugs Segment by Type

SSRI

TCA

Others

Obsessive-Compulsive Disorder Drugs Segment by Application

Clinic

Hospital

Research Institute

Other

Obsessive-Compulsive Disorder Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Obsessive-Compulsive Disorder Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Obsessive-Compulsive Disorder Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Obsessive-Compulsive Disorder Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Obsessive-Compulsive Disorder Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Obsessive-Compulsive Disorder Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Obsessive-Compulsive Disorder Drugs revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Obsessive-Compulsive Disorder Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. SSRI Major Player Table 3. TCA Major Player Table 4. Others Major Player Table 5. Global Obsessive-Compulsive Disorder Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Clinic Major Player Table 7. Hospital Major Player Table 8. Research Institute Major Player Table 9. Other Major Player Table 10. Obsessive-Compulsive Disorder Drugs Industry Trends Table 11. Obsessive-Compulsive Disorder Drugs Industry Drivers Table 12. Obsessive-Compulsive Disorder Drugs Industry Opportunities and Challenges Table 13. Obsessive-Compulsive Disorder Drugs Industry Restraints Table 14. Global Obsessive-Compulsive Disorder Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Obsessive-Compulsive Disorder Drugs Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Obsessive-Compulsive Disorder Drugs Market Share by Region (2021-2026) Table 17. Global Obsessive-Compulsive Disorder Drugs Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Obsessive-Compulsive Disorder Drugs Market Share by Region (2027-2032) Table 19. Global Obsessive-Compulsive Disorder Drugs Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Players (2021-2026) Table 21. Global Obsessive-Compulsive Disorder Drugs Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Obsessive-Compulsive Disorder Drugs Key Players Headquarters & Area Served Table 23. Global Obsessive-Compulsive Disorder Drugs Players, Product Type & Application Table 24. Global Obsessive-Compulsive Disorder Drugs Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Obsessive-Compulsive Disorder Drugs by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Obsessive-Compulsive Disorder Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Obsessive-Compulsive Disorder Drugs Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Obsessive-Compulsive Disorder Drugs Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Type (2021-2026) Table 31. Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Type (2027-2032) Table 32. Global Obsessive-Compulsive Disorder Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Obsessive-Compulsive Disorder Drugs Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Obsessive-Compulsive Disorder Drugs Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Application (2021-2026) Table 36. Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Application (2027-2032) Table 37. H. Lundbeck AS Company Information Table 38. H. Lundbeck AS Business Overview Table 39. H. Lundbeck AS Obsessive-Compulsive Disorder Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. H. Lundbeck AS Obsessive-Compulsive Disorder Drugs Product Portfolio Table 41. H. Lundbeck AS Recent Development Table 42. GlaxoSmithKline Plc Company Information Table 43. GlaxoSmithKline Plc Business Overview Table 44. GlaxoSmithKline Plc Obsessive-Compulsive Disorder Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. GlaxoSmithKline Plc Obsessive-Compulsive Disorder Drugs Product Portfolio Table 46. GlaxoSmithKline Plc Recent Development Table 47. Pfizer Inc. Company Information Table 48. Pfizer Inc. Business Overview Table 49. Pfizer Inc. Obsessive-Compulsive Disorder Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Pfizer Inc. Obsessive-Compulsive Disorder Drugs Product Portfolio Table 51. Pfizer Inc. Recent Development Table 52. Eli Lilly and Co. Company Information Table 53. Eli Lilly and Co. Business Overview Table 54. Eli Lilly and Co. Obsessive-Compulsive Disorder Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Eli Lilly and Co. Obsessive-Compulsive Disorder Drugs Product Portfolio Table 56. Eli Lilly and Co. Recent Development Table 57. Novartis AG Company Information Table 58. Novartis AG Business Overview Table 59. Novartis AG Obsessive-Compulsive Disorder Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Novartis AG Obsessive-Compulsive Disorder Drugs Product Portfolio Table 61. Novartis AG Recent Development Table 62. North America Obsessive-Compulsive Disorder Drugs Revenue by Type (2021-2026) & (US$ Million) Table 63. North America Obsessive-Compulsive Disorder Drugs Revenue by Type (2027-2032) & (US$ Million) Table 64. North America Obsessive-Compulsive Disorder Drugs Revenue by Application (2021-2026) & (US$ Million) Table 65. North America Obsessive-Compulsive Disorder Drugs Revenue by Application (2027-2032) & (US$ Million) Table 66. North America Obsessive-Compulsive Disorder Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 67. North America Obsessive-Compulsive Disorder Drugs Revenue by Country (2021-2026) & (US$ Million) Table 68. North America Obsessive-Compulsive Disorder Drugs Revenue by Country (US$ Million) & (2027-2032) Table 69. Europe Obsessive-Compulsive Disorder Drugs Revenue by Type (2021-2026) & (US$ Million) Table 70. Europe Obsessive-Compulsive Disorder Drugs Revenue by Type (2027-2032) & (US$ Million) Table 71. Europe Obsessive-Compulsive Disorder Drugs Revenue by Application (2021-2026) & (US$ Million) Table 72. Europe Obsessive-Compulsive Disorder Drugs Revenue by Application (2027-2032) & (US$ Million) Table 73. Europe Obsessive-Compulsive Disorder Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. Europe Obsessive-Compulsive Disorder Drugs Revenue by Country (2021-2026) & (US$ Million) Table 75. Europe Obsessive-Compulsive Disorder Drugs Revenue by Country (US$ Million) & (2027-2032) Table 76. China Obsessive-Compulsive Disorder Drugs Revenue by Type (2021-2026) & (US$ Million) Table 77. China Obsessive-Compulsive Disorder Drugs Revenue by Type (2027-2032) & (US$ Million) Table 78. China Obsessive-Compulsive Disorder Drugs Revenue by Application (2021-2026) & (US$ Million) Table 79. China Obsessive-Compulsive Disorder Drugs Revenue by Application (2027-2032) & (US$ Million) Table 80. Asia Obsessive-Compulsive Disorder Drugs Revenue by Type (2021-2026) & (US$ Million) Table 81. Asia Obsessive-Compulsive Disorder Drugs Revenue by Type (2027-2032) & (US$ Million) Table 82. Asia Obsessive-Compulsive Disorder Drugs Revenue by Application (2021-2026) & (US$ Million) Table 83. Asia Obsessive-Compulsive Disorder Drugs Revenue by Application (2027-2032) & (US$ Million) Table 84. Asia Obsessive-Compulsive Disorder Drugs Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 85. Asia Obsessive-Compulsive Disorder Drugs Revenue by Region (US$ Million) & (2021-2026) Table 86. Asia Obsessive-Compulsive Disorder Drugs Revenue by Region (US$ Million) & (2027-2032) Table 87. SAMEA Obsessive-Compulsive Disorder Drugs Revenue by Type (2021-2026) & (US$ Million) Table 88. SAMEA Obsessive-Compulsive Disorder Drugs Revenue by Type (2027-2032) & (US$ Million) Table 89. SAMEA Obsessive-Compulsive Disorder Drugs Revenue by Application (2021-2026) & (US$ Million) Table 90. SAMEA Obsessive-Compulsive Disorder Drugs Revenue by Application (2027-2032) & (US$ Million) Table 91. SAMEA Obsessive-Compulsive Disorder Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. SAMEA Obsessive-Compulsive Disorder Drugs Revenue by Country (2021-2026) & (US$ Million) Table 93. SAMEA Obsessive-Compulsive Disorder Drugs Revenue by Country (US$ Million) & (2027-2032) Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Obsessive-Compulsive Disorder Drugs Image Figure 2. Global Obsessive-Compulsive Disorder Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Obsessive-Compulsive Disorder Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. SSRI Image Figure 5. TCA Image Figure 6. Others Image Figure 7. Global Obsessive-Compulsive Disorder Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Obsessive-Compulsive Disorder Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Clinic Image Figure 10. Hospital Image Figure 11. Research Institute Image Figure 12. Other Image Figure 13. Global Obsessive-Compulsive Disorder Drugs Market Size (US$ Million) & (2021-2032) Figure 14. Global Obsessive-Compulsive Disorder Drugs Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Obsessive-Compulsive Disorder Drugs Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Obsessive-Compulsive Disorder Drugs Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Obsessive-Compulsive Disorder Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Obsessive-Compulsive Disorder Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Type (2021-2032) Figure 21. Global Obsessive-Compulsive Disorder Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Application (2021-2032) Figure 24. North America Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Obsessive-Compulsive Disorder Drugs Revenue Share by Type (2021-2032) Figure 26. North America Obsessive-Compulsive Disorder Drugs Revenue Share by Application (2021-2032) Figure 27. North America Obsessive-Compulsive Disorder Drugs Revenue Share by Country (2021-2032) Figure 28. United States Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Obsessive-Compulsive Disorder Drugs Revenue Share by Type (2021-2032) Figure 33. Europe Obsessive-Compulsive Disorder Drugs Revenue Share by Application (2021-2032) Figure 34. Europe Obsessive-Compulsive Disorder Drugs Revenue Share by Country (2021-2032) Figure 35. Germany Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Obsessive-Compulsive Disorder Drugs Revenue Share by Type (2021-2032) Figure 45. China Obsessive-Compulsive Disorder Drugs Revenue Share by Application (2021-2032) Figure 46. Asia Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Obsessive-Compulsive Disorder Drugs Revenue Share by Type (2021-2032) Figure 48. Asia Obsessive-Compulsive Disorder Drugs Revenue Share by Application (2021-2032) Figure 49. Asia Obsessive-Compulsive Disorder Drugs Revenue Share by Region (2021-2032) Figure 50. Japan Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Obsessive-Compulsive Disorder Drugs Revenue Share by Type (2021-2032) Figure 58. SAMEA Obsessive-Compulsive Disorder Drugs Revenue Share by Application (2021-2032) Figure 59. SAMEA Obsessive-Compulsive Disorder Drugs Revenue Share by Country (2021-2032) Figure 60. Brazil Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Obsessive-Compulsive Disorder Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • SSRI
  • TCA
  • Others
Applications
  • Clinic
  • Hospital
  • Research Institute
  • Other
Companies covered
  • H. Lundbeck AS
  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • Eli Lilly and Co.
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Obsessive-Compulsive Disorder Drugs Market by Type
  3. 1.2.1 Global Obsessive-Compulsive Disorder Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 SSRI
  5. 1.2.3 TCA
  6. 1.2.4 Others
  7. 1.3 Obsessive-Compulsive Disorder Drugs Market by Application
  8. 1.3.1 Global Obsessive-Compulsive Disorder Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Clinic
  10. 1.3.3 Hospital
  11. 1.3.4 Research Institute
  12. 1.3.5 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Obsessive-Compulsive Disorder Drugs Market Dynamics
  1. 2.1 Obsessive-Compulsive Disorder Drugs Industry Trends
  2. 2.2 Obsessive-Compulsive Disorder Drugs Industry Drivers
  3. 2.3 Obsessive-Compulsive Disorder Drugs Industry Opportunities and Challenges
  4. 2.4 Obsessive-Compulsive Disorder Drugs Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Obsessive-Compulsive Disorder Drugs Market Perspective (2021-2032)
  2. 3.2 Global Obsessive-Compulsive Disorder Drugs Growth Trends by Region
  3. 3.2.1 Global Obsessive-Compulsive Disorder Drugs Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Obsessive-Compulsive Disorder Drugs Market Size by Region (2021-2026)
  5. 3.2.3 Global Obsessive-Compulsive Disorder Drugs Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Obsessive-Compulsive Disorder Drugs Revenue by Players
  2. 4.1.1 Global Obsessive-Compulsive Disorder Drugs Revenue by Players (2021-2026)
  3. 4.1.2 Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Obsessive-Compulsive Disorder Drugs Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Obsessive-Compulsive Disorder Drugs Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Obsessive-Compulsive Disorder Drugs Key Players Headquarters & Area Served
  7. 4.4 Global Obsessive-Compulsive Disorder Drugs Players, Product Type & Application
  8. 4.5 Global Obsessive-Compulsive Disorder Drugs Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Obsessive-Compulsive Disorder Drugs Market CR5 and HHI
  11. 4.6.3 2025 Obsessive-Compulsive Disorder Drugs Tier 1, Tier 2, and Tier 3
5 Obsessive-Compulsive Disorder Drugs Market Size by Type
  1. 5.1 Global Obsessive-Compulsive Disorder Drugs Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Obsessive-Compulsive Disorder Drugs Revenue by Type (2021-2032)
  3. 5.3 Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Type (2021-2032)
6 Obsessive-Compulsive Disorder Drugs Market Size by Application
  1. 6.1 Global Obsessive-Compulsive Disorder Drugs Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Obsessive-Compulsive Disorder Drugs Revenue by Application (2021-2032)
  3. 6.3 Global Obsessive-Compulsive Disorder Drugs Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 H. Lundbeck AS
  2. 7.1.1 H. Lundbeck AS Company Information
  3. 7.1.2 H. Lundbeck AS Business Overview
  4. 7.1.3 H. Lundbeck AS Obsessive-Compulsive Disorder Drugs Revenue and Gross Margin (2021-2026)
  5. 7.1.4 H. Lundbeck AS Obsessive-Compulsive Disorder Drugs Product Portfolio
  6. 7.1.5 H. Lundbeck AS Recent Developments
  7. 7.2 GlaxoSmithKline Plc
  8. 7.2.1 GlaxoSmithKline Plc Company Information
  9. 7.2.2 GlaxoSmithKline Plc Business Overview
  10. 7.2.3 GlaxoSmithKline Plc Obsessive-Compulsive Disorder Drugs Revenue and Gross Margin (2021-2026)
  11. 7.2.4 GlaxoSmithKline Plc Obsessive-Compulsive Disorder Drugs Product Portfolio
  12. 7.2.5 GlaxoSmithKline Plc Recent Developments
  13. 7.3 Pfizer Inc.
  14. 7.3.1 Pfizer Inc. Company Information
  15. 7.3.2 Pfizer Inc. Business Overview
  16. 7.3.3 Pfizer Inc. Obsessive-Compulsive Disorder Drugs Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Inc. Obsessive-Compulsive Disorder Drugs Product Portfolio
  18. 7.3.5 Pfizer Inc. Recent Developments
  19. 7.4 Eli Lilly and Co.
  20. 7.4.1 Eli Lilly and Co. Company Information
  21. 7.4.2 Eli Lilly and Co. Business Overview
  22. 7.4.3 Eli Lilly and Co. Obsessive-Compulsive Disorder Drugs Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Eli Lilly and Co. Obsessive-Compulsive Disorder Drugs Product Portfolio
  24. 7.4.5 Eli Lilly and Co. Recent Developments
  25. 7.5 Novartis AG
  26. 7.5.1 Novartis AG Company Information
  27. 7.5.2 Novartis AG Business Overview
  28. 7.5.3 Novartis AG Obsessive-Compulsive Disorder Drugs Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Novartis AG Obsessive-Compulsive Disorder Drugs Product Portfolio
  30. 7.5.5 Novartis AG Recent Developments
8 North America
  1. 8.1 North America Obsessive-Compulsive Disorder Drugs Revenue (2021-2032)
  2. 8.2 North America Obsessive-Compulsive Disorder Drugs Revenue by Type (2021-2032)
  3. 8.2.1 North America Obsessive-Compulsive Disorder Drugs Revenue by Type (2021-2026)
  4. 8.2.2 North America Obsessive-Compulsive Disorder Drugs Revenue by Type (2027-2032)
  5. 8.3 North America Obsessive-Compulsive Disorder Drugs Revenue Share by Type (2021-2032)
  6. 8.4 North America Obsessive-Compulsive Disorder Drugs Revenue by Application (2021-2032)
  7. 8.4.1 North America Obsessive-Compulsive Disorder Drugs Revenue by Application (2021-2026)
  8. 8.4.2 North America Obsessive-Compulsive Disorder Drugs Revenue by Application (2027-2032)
  9. 8.5 North America Obsessive-Compulsive Disorder Drugs Revenue Share by Application (2021-2032)
  10. 8.6 North America Obsessive-Compulsive Disorder Drugs Revenue by Country
  11. 8.6.1 North America Obsessive-Compulsive Disorder Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Obsessive-Compulsive Disorder Drugs Revenue by Country (2021-2026)
  13. 8.6.3 North America Obsessive-Compulsive Disorder Drugs Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Obsessive-Compulsive Disorder Drugs Revenue (2021-2032)
  2. 9.2 Europe Obsessive-Compulsive Disorder Drugs Revenue by Type (2021-2032)
  3. 9.2.1 Europe Obsessive-Compulsive Disorder Drugs Revenue by Type (2021-2026)
  4. 9.2.2 Europe Obsessive-Compulsive Disorder Drugs Revenue by Type (2027-2032)
  5. 9.3 Europe Obsessive-Compulsive Disorder Drugs Revenue Share by Type (2021-2032)
  6. 9.4 Europe Obsessive-Compulsive Disorder Drugs Revenue by Application (2021-2032)
  7. 9.4.1 Europe Obsessive-Compulsive Disorder Drugs Revenue by Application (2021-2026)
  8. 9.4.2 Europe Obsessive-Compulsive Disorder Drugs Revenue by Application (2027-2032)
  9. 9.5 Europe Obsessive-Compulsive Disorder Drugs Revenue Share by Application (2021-2032)
  10. 9.6 Europe Obsessive-Compulsive Disorder Drugs Revenue by Country
  11. 9.6.1 Europe Obsessive-Compulsive Disorder Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Obsessive-Compulsive Disorder Drugs Revenue by Country (2021-2026)
  13. 9.6.3 Europe Obsessive-Compulsive Disorder Drugs Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Obsessive-Compulsive Disorder Drugs Revenue (2021-2032)
  2. 10.2 China Obsessive-Compulsive Disorder Drugs Revenue by Type (2021-2032)
  3. 10.2.1 China Obsessive-Compulsive Disorder Drugs Revenue by Type (2021-2026)
  4. 10.2.2 China Obsessive-Compulsive Disorder Drugs Revenue by Type (2027-2032)
  5. 10.3 China Obsessive-Compulsive Disorder Drugs Revenue Share by Type (2021-2032)
  6. 10.4 China Obsessive-Compulsive Disorder Drugs Revenue by Application (2021-2032)
  7. 10.4.1 China Obsessive-Compulsive Disorder Drugs Revenue by Application (2021-2026)
  8. 10.4.2 China Obsessive-Compulsive Disorder Drugs Revenue by Application (2027-2032)
  9. 10.5 China Obsessive-Compulsive Disorder Drugs Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Obsessive-Compulsive Disorder Drugs Revenue (2021-2032)
  2. 11.2 Asia Obsessive-Compulsive Disorder Drugs Revenue by Type (2021-2032)
  3. 11.2.1 Asia Obsessive-Compulsive Disorder Drugs Revenue by Type (2021-2026)
  4. 11.2.2 Asia Obsessive-Compulsive Disorder Drugs Revenue by Type (2027-2032)
  5. 11.3 Asia Obsessive-Compulsive Disorder Drugs Revenue Share by Type (2021-2032)
  6. 11.4 Asia Obsessive-Compulsive Disorder Drugs Revenue by Application (2021-2032)
  7. 11.4.1 Asia Obsessive-Compulsive Disorder Drugs Revenue by Application (2021-2026)
  8. 11.4.2 Asia Obsessive-Compulsive Disorder Drugs Revenue by Application (2027-2032)
  9. 11.5 Asia Obsessive-Compulsive Disorder Drugs Revenue Share by Application (2021-2032)
  10. 11.6 Asia Obsessive-Compulsive Disorder Drugs Revenue by Country
  11. 11.6.1 Asia Obsessive-Compulsive Disorder Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Obsessive-Compulsive Disorder Drugs Revenue by Country (2021-2026)
  13. 11.6.3 Asia Obsessive-Compulsive Disorder Drugs Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Obsessive-Compulsive Disorder Drugs Revenue (2021-2032)
  2. 12.2 SAMEA Obsessive-Compulsive Disorder Drugs Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Obsessive-Compulsive Disorder Drugs Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Obsessive-Compulsive Disorder Drugs Revenue by Type (2027-2032)
  5. 12.3 SAMEA Obsessive-Compulsive Disorder Drugs Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Obsessive-Compulsive Disorder Drugs Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Obsessive-Compulsive Disorder Drugs Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Obsessive-Compulsive Disorder Drugs Revenue by Application (2027-2032)
  9. 12.5 SAMEA Obsessive-Compulsive Disorder Drugs Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Obsessive-Compulsive Disorder Drugs Revenue by Country
  11. 12.6.1 SAMEA Obsessive-Compulsive Disorder Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Obsessive-Compulsive Disorder Drugs Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Obsessive-Compulsive Disorder Drugs Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst